Guideline Panel Meeting: Translating Comparative Effectiveness Research Using the GRADE Approach (2018)

November 17, 2018 to November 18, 2018

Judgments about evidence and recommendations in healthcare are complex. Systematic reviews of the effects of healthcare provide essential, but not sufficient information for making well informed decisions. Reviewers and people who use reviews draw conclusions about the quality of the evidence, either implicitly or explicitly. Such judgments guide subsequent decisions. For example, clinical actions are likely to differ depending on whether one concludes that the evidence that warfarin reduces the risk of stroke in patients with atrial fibrillation is convincing (high quality) or that it is unconvincing (low quality).A systematic and explicit approach to making judgments such as these can help to prevent errors, facilitate critical appraisal of these judgments, and can help to improve communication of this information to providers, patients and researchers.

Target Audience

This course is designed for:

  • Urologists

Learning Objectives

After completing this activity, particpants will be able to:

  1. Utilize the GRADE approach to improve judgement and prevent errors.
  2. Perform critical appraisal of judgments based on the GRADE approach.
  3. Integrate communication of the GRADE approach.
  4. Compare CER and other medical literature.
Course summary
Available credit: 
  • 11.00 AMA PRA Category 1 Credit™
  • 11.00 Non-Physician Participation
Course opens: 
Course expires: 
Event starts: 
11/17/2018 - 6:00am EST
Event ends: 
11/18/2018 - 12:00pm EST

Saturday, November 17, 2018


7:00 – 8:00 a.m.               Registration and Breakfast


8:00 -08:15 a.m.               Welcome and Workshop Overview (Dahm)


8:15 -9:00 a.m.                 Plenary: Creating Trustworthy Guidelines and GRADE (Murad)


9:00 – 9:30 a.m.                Plenary: Focused Clinical Questions and Patient Important Outcomes (Dahm)


9:30 – 9:45  a.m.               Break


9:45 -10:45 a.m.               Plenary: Randomized trials – Rating Down for Risk of Bias (Dahm)


10:45a.m.  – 12:00 pm     Hands-on Session: Assessing Risk of Bias and Rating outcomes


12:00 – 1:00 p.m.             Lunch


1:00 pm -2:00 p.m.           Plenary: Non-randomized trials – Risk of Bias and Rating Up (Murad)


2:00 -3:00 p.m.                 Plenary: Rating the Certainty of Evidence using GRADE (Dahm)


3:00 – 3:15 pm                  Break


3:15 – 4:45 pm                  Hands-on Session: Rating the Certainty of Evidence


4:45 – 5:00 pm                  Q & A


5:00 p.m.                           Adjourn




Sunday November 18, 2018


08:00 -08:30 a.m.             Breakfast


08:30 -09:30 a.m.             Plenary: From Evidence to Recommendations (Dahm)


9:00 – 9:15 a.m.               Break


09:15 -10:45 a.m.             Mock Panel Meeting: Applying the GRADE Evidence-to-Decision Framework


10:45 -11:00 a.m.              Break


11:00 – 11:30 am              Advanced concepts (Murad)


11:30 a.m.-12:00 p.m.      Q & A, Workshop Feedback


12:00 p.m.                         Adjourn

AUA Headquarters
Linthicum, MD 21090
United States





Philipp Dahm, MD

Nothing to disclose


M. Hassan Murad, MD

Nothing to disclose


Education Council Disclosures:




Victor Nitti, MD
(AUA Chair of Education)


Health Publishing, Scientific Study or Trial




Health Publishing, Scientific Study or Trial



Serenity Pharmeuticals

Investment Interest




Scientific Study or Trial


Michael Abern, MD
(AUA Chair of COI Review Work Group)

Dept. of Defense Prostate Cancer Research Program

Scientific study or Trial, Consultant or Advisor



American Urological Association Office of Edu

Consultant or Advisor


Heddy Hubbard, PhD


Nothing to disclose



Abid Khan, MPH


Nothing to disclose



Leila Rahimi, MPH


Nothing to disclose



Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity for a maximum of 11.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 CreditTM.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Work Group or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 11.00 AMA PRA Category 1 Credit™
  • 11.00 Non-Physician Participation
Please login or register to take this course.

This activity is restricted to attendees of The Translating Comparative Effectiveness Research Using the GRADE Approach.